Drug intelligence / Profile preview

keto-analogs of essential amino acids

Development stage
Unknown
Lead developer
Fresenius Kabi
Modality
Small Molecules
Administration
Oral
01

Overview

Keto-analogs of essential amino acids (often referred to as keto acids) are a group of nitrogen-free precursors used primarily in the nutritional management of chronic kidney disease (CKD). In a randomized controlled trial conducted by Peking University First Hospital, these supplements were evaluated for their impact on insulin resistance and metabolic markers in patients undergoing peritoneal dialysis. The mechanism of action involves the transamination of the keto-analogs into their corresponding essential amino acids by utilizing excess nitrogen from urea, thereby reducing nitrogenous waste and uremic toxin production while providing necessary nutrients. Although the primary endpoint of improving insulin resistance (measured by HOMA-IR) was not significantly different between groups in the Peking University study, the intervention demonstrated secondary benefits in reducing systemic inflammation (hs-CRP) and improving the leptin/adiponectin ratio (LAR), suggesting potential metabolic and cardiovascular benefits in dialysis patients.

Brand names
Ketosteril
Other names
keto acidsketoanalogsketoanaloguesalpha-keto analogues of essential amino acids

Beyond the preview

Go deeper on keto-analogs of essential amino acids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on keto-analogs of essential amino acids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call